8 Strategic Questions to Help Determine Your Path to Virtualization
8 Strategic Questions to Help Determine Your Path to Decentralization
What was once an emergent market trend is now an established market need: decentralized clinical trial technology. Decentralized clinical trials, also known as virtual or hybrid trials, were already increasingly appealing, but as of late there has been a rapid acceleration in decentralized trial technology adoption.
In this eBook, we’ve compiled eight strategic questions that will help jumpstart your path to decentralized clinical trials (DCTs), including:
- What qualifies as a decentralized clinical trial
- What decentralizing technology means for study teams
- How decentralization benefits patients, sites, and sponsors